Brief: Kyverna Therapeutics Appoints Nadia Dac, Seasoned Commercial Leader In Neurology And Rare Disease, As Chief Commercial Officer
04/05/2026 13:07
May 4 (Reuters) - Kyverna Therapeutics Inc KYTX.O: KYVERNA THERAPEUTICS APPOINTS NADIA DAC, SEASONED COMMERCIAL LEADER IN NEUROLOGY AND RARE DISEASE, AS CHIEF COMMERCIAL OFFICER Source text: ID:nGNX87RtRp Further company coverage: KYTX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kyverna Therapeutics
See all newsHealth Rounds: Appendix removal linked with lower colon cancer risk in study
U.S. STOCKS ON THE MOVE-Charles River, Oracle, TD Synnex
US STOCKS ON THE MOVE-Charles River, Oracle, TD Synnex
U.S. STOCKS ON THE MOVE-CoreWeave, Versant Media, BlackBerry
U.S. STOCKS ON THE MOVE-Everpure, Dropbox, Darden Restaurants